Naltrexone-bupropion, marketed under the brand name Contrave, remains a widely recognized and effective prescription weight loss medication in 2026. This fixed-dose combination combines naltrexone (an opioid receptor antagonist) and bupropion (a norepinephrine-dopamine reuptake inhibitor) to target central appetite regulation pathways in the brain. By modulating reward circuits, reducing food cravings, and increasing satiety signals, Contrave […]